Nanjing Hicin Pharmaceutical Co., Ltd. (SHE:300584)
China
· Delayed Price · Currency is CNY 27.48
+4.58 (20.00%)
May 21, 2025, 2:45 PM CST
SHE:300584 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | May '25 May 20, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 3,298 | 2,419 | 2,794 | 3,864 | 2,400 | 2,462 | Upgrade
|
| Market Cap Growth | 12.86% | -13.40% | -27.70% | 61.00% | -2.53% | -27.13% | Upgrade
|
| Enterprise Value | 3,577 | 2,671 | 2,943 | 3,897 | 2,479 | 2,522 | Upgrade
|
| Last Close Price | 27.48 | 20.16 | 23.21 | 32.10 | 19.79 | 20.17 | Upgrade
|
| PE Ratio | 78.72 | 60.15 | 76.93 | 119.08 | 8.40 | 44.58 | Upgrade
|
| Forward PE | - | 26.20 | 26.20 | 26.20 | 26.20 | 26.20 | Upgrade
|
| PS Ratio | 6.08 | 4.80 | 5.40 | 7.34 | 4.15 | 3.49 | Upgrade
|
| PB Ratio | 3.13 | 2.33 | 2.83 | 4.07 | 2.53 | 3.63 | Upgrade
|
| P/TBV Ratio | 3.64 | 2.74 | 3.25 | 4.73 | 2.90 | 4.19 | Upgrade
|
| P/FCF Ratio | 145.46 | - | - | - | - | - | Upgrade
|
| P/OCF Ratio | 33.50 | 40.35 | 116.73 | - | 40.04 | 33.55 | Upgrade
|
| EV/Sales Ratio | 6.59 | 5.30 | 5.68 | 7.40 | 4.29 | 3.57 | Upgrade
|
| EV/EBITDA Ratio | 31.88 | 23.67 | 30.35 | 47.13 | 37.32 | 25.96 | Upgrade
|
| EV/EBIT Ratio | 60.20 | 44.57 | 67.63 | 112.54 | 84.27 | 38.45 | Upgrade
|
| EV/FCF Ratio | 157.80 | - | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.30 | 0.30 | 0.27 | 0.19 | 0.19 | 0.25 | Upgrade
|
| Debt / EBITDA Ratio | 2.81 | 2.79 | 2.79 | 2.15 | 2.71 | 1.75 | Upgrade
|
| Debt / FCF Ratio | 13.93 | - | - | - | - | - | Upgrade
|
| Asset Turnover | 0.38 | 0.35 | 0.38 | 0.41 | 0.52 | 0.80 | Upgrade
|
| Inventory Turnover | 0.99 | 1.02 | 1.39 | 2.24 | 1.74 | 2.40 | Upgrade
|
| Quick Ratio | 0.70 | 0.74 | 0.73 | 0.96 | 0.79 | 1.22 | Upgrade
|
| Current Ratio | 1.01 | 1.07 | 0.94 | 1.19 | 1.00 | 1.62 | Upgrade
|
| Return on Equity (ROE) | 4.07% | 3.96% | 3.75% | 3.38% | 35.00% | 8.18% | Upgrade
|
| Return on Assets (ROA) | 2.57% | 2.61% | 2.01% | 1.67% | 1.67% | 4.62% | Upgrade
|
| Return on Capital (ROIC) | 2.81% | 2.87% | 2.28% | 1.92% | 1.86% | 5.04% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.20% | 5.30% | 4.30% | 3.50% | 2.90% | 9.00% | Upgrade
|
| Earnings Yield | 1.27% | 1.66% | 1.30% | 0.84% | 11.91% | 2.24% | Upgrade
|
| FCF Yield | 0.69% | -0.74% | -6.20% | -5.82% | -1.44% | -1.90% | Upgrade
|
| Dividend Yield | 0.22% | - | 0.21% | - | 1.26% | 0.62% | Upgrade
|
| Payout Ratio | 33.24% | 34.44% | 17.80% | 109.40% | 7.70% | 66.97% | Upgrade
|
| Buyback Yield / Dilution | 0.01% | -0.01% | -0.01% | -0.00% | -0.01% | 0.01% | Upgrade
|
| Total Shareholder Return | 0.22% | -0.01% | 0.21% | -0.00% | 1.25% | 0.63% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.